Crossmark

Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype

Crossref DOI link: https://doi.org/10.1007/s00125-020-05114-7

Published Online: 2020-03-10

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hanna, Stephanie J. https://orcid.org/0000-0002-0821-4498
Powell, Wendy E.

Long, Anna E.

Robinson, Emma J. S.

Davies, Joanne

Megson, Clare

Howell, Alexandra

Jones, Taz J.

Ladell, Kristin

Price, David A.

Dayan, Colin M.

Williams, Alistair J. K.

Gillespie, Kathleen M.

Wong, F. Susan
Funding

Funding for this research was provided by:

Diabetes UK (18/0005778)

Wellcome Trust (100326/Z/12/Z)

JDRF (3-APF-2018-591-A-N)
License Information

Text and Data Mining valid from 2020-03-10

Version of Record valid from 2020-03-10
More Information

Article History

Received: 12 September 2019

Accepted: 13 January 2020

First Online: 10 March 2020

Authors’ relationships and activities

: The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.

Document is current

Any future updates will be listed below